Blogs

13
May 2025

Speed vs. Sensitivity in CCI Testing - Finding the Right Balance in High-Risk Applications

Speed-vs-Sensitivity-in-CCI-Testing-Finding-the-Right-Balance-in-High-Risk-Applications

In the world of pharmaceutical packaging, where patient safety is non-negotiable, Container Closure Integrity Testing (CCIT) serves as a crucial safeguard. From sterile injectables to biologics and combination products, the integrity of a container-closure system can be the fine line between safety and risk. But as companies strive to optimize production efficiency, a recurring question emerges—how do we balance speed and sensitivity in package integrity testingpackage integrity testing, especially for high-risk applications?

Why Sensitivity Matters in High-Risk Applications

Imagine a life-saving biologic that loses sterility due to a microleak. The patient impact could be devastating. This is why sensitivity in CCIT isn't just a technical requirement—it’s a moral imperative.

High-risk products such as injectable biologics, ophthalmic solutions, or combination devices require maximum sensitivity to detect even the tiniest breaches in the container. These products are often sensitive to oxygen, moisture, or microbial ingress, and even a microscopic-defect can compromise their efficacy or safety. Traditional probabilistic methods like dye ingress or bubble emission simply lack the precision required for these applications. That's where deterministic technologies, especially High Voltage Leak Detection (HVLD), step in.

MicroCurrent High Voltage Leak Detection (HVLD) is a non-destructive method used in Container Closure Integrity Testing (CCIT), specifically designed to assess the integrity of parenteral packaging systems. This advanced testing technique is based on quantitative electrical conductivity measurements.

The principle of HVLDmc involves applying a low current signal across the package or container. In the presence of a leak, the electrical resistance of the package drops, leading to an increase in current—signaling a defect. MicroCurrent HVLD is particularly effective for liquid-filled, non-conductive containers and is applicable to a wide range of packaging formats, including:

  • Pre-filled syringes
  • Ampoules
  • Drug product cartridges
  • Liquid-filled vials
  • Blow-Fill-Seal (BFS) containers

PTI’s MicroCurrent HVLD: Advancing Traditional HVLD Technology

PTI has redefined HVLD with the introduction of its MicroCurrent HVLD technology—a highly sensitive, non-invasive, and non-destructive CCIT method. This innovative approach extends the capabilities of conventional HVLD by using significantly lower voltages and currents, making it safer for delicate drug products and sensitive environments.

MicroCurrent HVLD is particularly suitable for testing liquid-filled containers, including challenging formulations such as low-conductivity sterile water for injection (WFI) and protein-rich drug suspensions.

PTI’s E-Scan HVLD system employs electrode probes to scan sealed, non-conductive containers. When a breach is present, the resulting variation in current flow identifies both the presence and approximate location of the defect. One of the key advantages of this technique is its ability to use approximately 50% less voltage, reducing product and environmental exposure to less than 5% of traditional HVLD voltage levels.

Moreover, the E-Scan HVLD system offers unmatched flexibility, seamlessly transitioning from offline laboratory testing to 100% inline automated inspection. It supports various packaging materials, including glass, plastic, and poly-laminate containers, making it an ideal solution for comprehensive parenteral package integrity testing.

Benefits of MicroCurrent HVLD:

  • Deterministic, non-destructive, non-invasive
  • High level of repeatability and accuracy
  • Ideal package integrity solution for parenteral products
  • Low voltage exposure to the product and environment
  • Offline and 100% online inspection

In high-risk pharmaceutical applications, the choice between speed and sensitivity shouldn’t be a binary one. Instead, the goal should be to find a solution that optimizes both. Technologies like MicroCurrent HVLD offer a way forward—providing the precision required to detect critical defects, without sacrificing the throughput needed to meet production demands.

Readmore...
ccit, package integrity testing, hvld, helium leak testing
21

Popular Blogs

Tags

How to Leak Test High Risk Medical Device Packages

Jan 25, 2022   |   9723

Medical device leak testing is considered a critical step in ensuring package integrity primarily due to its sensitive nature. Leaks in the device can cause serious health risks to the patients and result in huge financial losses to the manufacturer. PTI's Seal-Scan technology is a non-destructive seal quality inspection technique for high risk pharmaceuticals and medical devices.

A Closer Look at PTI's Advanced Testing Services

Jun 27, 2024   |   8185

PTI offers advanced lab testing services across industries, safeguarding product integrity, safety, and regulatory adherence. Their expertise spans feasibility studies, test method development, stability testing, recall & batch release, and helium testing, all conducted by qualified professionals using advanced technologies.

Helium Leak Testing for Pharmaceuticals - PTI Offers Unmatched Solutions

Jul 15, 2024   |   7360

PTI offers unparalleled helium leak testing solutions for pharmaceutical packaging integrity. Our advanced services ensure high sensitivity and non-destructive testing, safeguarding product sterility and efficacy.

Decoding USP Standards - An In-Depth Look at USP <382>

Aug 02, 2024   |   7334

USP <382> sets new standards for assessing the functionality of elastomeric components in injectable drug packaging, emphasizing comprehensive container closure integrity testing to ensure safety and efficacy. Compliance by December 2025 is critical for pharmaceutical companies to maintain robust and reliable packaging systems.

Container Closure Integrity Testing (CCIT) - An Ideal Solution for the Pharmaceutical Industry

Sep 01, 2020   |   6998

Container Closure Integrity Testing is a method of leak detection using a non-destructive packaging inspection system to prevent possible contamination in pharmaceutical products.
ptiusa

Our technologies conform to ASTM and other regulatory standards.

Packaging Technologies & Inspection

PTI offers inspection systems for package leak testing, seal integrity and container closure integrity testing (CCIT). Our technologies exclude subjectivity from package testing, and use test methods that conform to ASTM standards. PTI's inspection technologies are deterministic test methods that produce quantitative test result data. We specialize in offering the entire solution including test method development and equipment validation.

Sales Channel Partner Portal Login

Get in Touch

 

Packaging Technologies & Inspection

PTI offers inspection systems for package leak testing, seal integrity and container closure integrity testing (CCIT). Our technologies exclude subjectivity from package testing, and use test methods that conform to ASTM standards. PTI's inspection technologies are deterministic test methods that produce quantitative test result data. We specialize in offering the entire solution including test method development and equipment validation.

Sales Channel Partner Portal Login

ptiusa

Our technologies conform to ASTM and other regulatory standards.

Get in Touch

 
Popup